1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Infusion of HS-IT101 Injection: new trials by email Literature Review of Infusion of HS-IT101 Injection trials Research Report on Infusion of HS-IT101 Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02） Tumor Tissue Sampling, Lymphodepletion Conditioning, Infusion of HS-IT101 Injection - Melanoma (Excluding Uveal Melanoma) | Phase 2 | Recruiting | Hangzhou Huasai Biomedicine Co., Ltd. | 90 | 2026-02-26 | 2026-10-27 |
Melanoma (1)
Hangzhou Huasai Biomedicine Co., Ltd. (1)
China (1)